Bipartisan Bill Proposed: What is Predicted of the Stock Market?

Politicians seem to have some of the best performing investment portfolios which is why the BiPartisan Restoring Faith in Government Act was introduced to prohibit congress member stock market trading. The bipartisan bill is sponsored by GOP Reps Matt Gaetz and Brian Fitzpatrick alongside Alexandria Ocasio-Cortez, amongst others.

On this episode of Untamed Ethos, host Dr. Joshua Wilson, who recently successfully defended his PhD dissertation, chats with guest Dr. Russell Rhoads, a Clinical Associate Professor at the Indiana University Kelley School of Business. The two discuss a new bipartisan bill that has been proposed that would prohibit stock trading in Congress.

Wilson was quick to propose that this marked a great opportunity for investment advisors to speak out in favor of the retail client. But in a capitalist society, should congress members be banned from being allowed to own stock and trade?

Rhoads noted, “If you go into Congress, you probably should, there should be some sort of mechanism in there where you get a money manager that, you know, uses one of those CFA, cookie-cutter solutions…and here’s how we’re going to allocate for you.”

Dr. Rhoads and Dr. Wilson also discuss…

● How current events affect market volatility

● Where the state of the stock market lies

● Rhoads’ prediction on the outlook of the stocks in the coming years

“The most favored number is a 25-basis point cut in September, and I just don’t see that happening and I gotta figure out how to go about trading this because the only way you can really make money trading fixed income is if you have a different opinion than the rest of the market,” said Rhoads.

Russell Rhoads, PhD, was previously head of research at EQDerivatives. He is now an Associate Clinical Professor at the Kelley School of Business at Indiana University. He has over three decades of experience in the trading and financial market industries. Rhoads is also a published author, including Candlestick Charting for Dummies, and The VIX Trader’s Handbook, amongst others.

Follow us on social media for the latest updates in B2B!

Image

Latest

AMAG Technology
AMAG Technology: Control, Reliability, and Customer-First Supply Chain Excellence
April 2, 2025

At AMAG Technology, being customer-obsessed goes beyond a mindset—it’s built into every part of the operation. One of the company’s greatest strengths lies in its ability to manufacture its own products, offering a level of supply chain control that few competitors can match. Allan Price, Head of Global Supply Chain at AMAG, emphasizes how this…

Read More
visitor management solution
Reinventing Visitor Management Solution with Symmetry GUEST
April 2, 2025

In an age where speed and security are paramount, the traditional paper logbook is becoming a relic of the past. AMAG Technology’s Symmetry Guest system offers a modern, digital solution that redefines the way organizations welcome and manage visitors. Gone are the days of long lines and confusion at the front desk—Symmetry Guest empowers hosts…

Read More
AMAG
Driven by Customers, Defined by Innovation: Inside AMAG’s Customer-Obsessed Approach
April 2, 2025

AMAG Technology continues to strengthen its customer-obsessed culture by actively listening to both internal and external voices. As shared by Kyle Gordon, Executive Vice President of Global Sales, Marketing, & Commercial Excellence, the company is focused on improving processes, responding with speed, and driving innovation—while honoring its legacy and delivering unique value within the industry.

Read More
biotech
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation
April 2, 2025

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion…

Read More